The genetic make-up of a cancer can be critical information for treating the disease. Some medications are designed to zero in on specific genetic defects to treat the cancer. Could this info be used before the cancer forms?

Women who have been through the breast cancer journey usually take some form of medication to keep the disease from returning. Are they taking more pills than women who've never had cancer?

New cancer medications and tests are in the news every day. What if a computer could keep track of all this information and help doctors offer you the best possible treatment options?

Thanks to Angelina Jolie, we have been hearing a lot about BRCA1 and BRCA2 gene mutations. But for some patients, these genes alone may not tell the whole story.

The body’s lymph system is a super highway for cancer to travel to other locations. A new study may change the way physicians treat women whose early breast cancer has spread to the lymph nodes. And this change could make the after-cancer ride a whole lot sweeter.

We learned last year at the San Antonio Breast Cancer Symposium (SABCS) that 10 years of tamoxifen treatment is better than what had been the standard five years. Another study sought to confirm these findings.

Mammography technology has just gotten a whole lot better, with less discomfort, less radiation and more precise views of breast tissue.

Even after a cancer is successfully treated, there's still a risk that another cancer may show up at some point down the line. A recent Spanish study looked at the risk of second cancers in breast cancer survivors.

The diabetes drug metformin has been something of a darling in the cancer world of late. Previous research has shown that it may help prevent or beat cancer. But a new study has come along that creates a question mark.